329 related articles for article (PubMed ID: 28603525)
21. Building immunity to cancer with radiation therapy.
Haikerwal SJ; Hagekyriakou J; MacManus M; Martin OA; Haynes NM
Cancer Lett; 2015 Nov; 368(2):198-208. PubMed ID: 25592036
[TBL] [Abstract][Full Text] [Related]
22. [Immunotherapy and radiotherapy].
Bockel S; Antoni D; Deutsch É; Mornex F
Cancer Radiother; 2017 May; 21(3):244-255. PubMed ID: 28522277
[TBL] [Abstract][Full Text] [Related]
23. Innate immune recognition of cancer.
Woo SR; Corrales L; Gajewski TF
Annu Rev Immunol; 2015; 33():445-74. PubMed ID: 25622193
[TBL] [Abstract][Full Text] [Related]
24. Modulation of inflammation by low and high doses of ionizing radiation: Implications for benign and malign diseases.
Frey B; Hehlgans S; Rödel F; Gaipl US
Cancer Lett; 2015 Nov; 368(2):230-7. PubMed ID: 25888451
[TBL] [Abstract][Full Text] [Related]
25. Optimal treatment scheduling of ionizing radiation and sunitinib improves the antitumor activity and allows dose reduction.
Kleibeuker EA; Ten Hooven MA; Castricum KC; Honeywell R; Griffioen AW; Verheul HM; Slotman BJ; Thijssen VL
Cancer Med; 2015 Jul; 4(7):1003-15. PubMed ID: 25828633
[TBL] [Abstract][Full Text] [Related]
26. Kill and spread the word: stimulation of antitumor immune responses in the context of radiotherapy.
Gaipl US; Multhoff G; Scheithauer H; Lauber K; Hehlgans S; Frey B; Rödel F
Immunotherapy; 2014; 6(5):597-610. PubMed ID: 24896628
[TBL] [Abstract][Full Text] [Related]
27. Co-targeting deoxyribonucleic acid-dependent protein kinase and poly(adenosine diphosphate-ribose) polymerase-1 promotes accelerated senescence of irradiated cancer cells.
Azad A; Bukczynska P; Jackson S; Haupt Y; Cullinane C; McArthur GA; Solomon B
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):385-94. PubMed ID: 24411611
[TBL] [Abstract][Full Text] [Related]
28. Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation.
Gewirtz DA; Holt SE; Elmore LW
Biochem Pharmacol; 2008 Oct; 76(8):947-57. PubMed ID: 18657518
[TBL] [Abstract][Full Text] [Related]
29. Combining radiotherapy and immunotherapy: a revived partnership.
Demaria S; Bhardwaj N; McBride WH; Formenti SC
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):655-66. PubMed ID: 16199306
[TBL] [Abstract][Full Text] [Related]
30. [Death inducing ligands in combination with ionizing radiation: objective and current knowledge].
Belka C; Betsch A; Marini P; Jendrossek V; Bamberg M; Budach W
Strahlenther Onkol; 2003 Mar; 179(3):141-51. PubMed ID: 12627256
[TBL] [Abstract][Full Text] [Related]
31. Radiation therapy and immunotherapy: implications for a combined cancer treatment.
Levy A; Chargari C; Cheminant M; Simon N; Bourgier C; Deutsch E
Crit Rev Oncol Hematol; 2013 Mar; 85(3):278-87. PubMed ID: 23036459
[TBL] [Abstract][Full Text] [Related]
32. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
33. Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer.
Roses RE; Xu M; Koski GK; Czerniecki BJ
Oncogene; 2008 Jan; 27(2):200-7. PubMed ID: 18176601
[TBL] [Abstract][Full Text] [Related]
34. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
35. From cancer immunosurveillance to cancer immunotherapy.
Stagg J; Johnstone RW; Smyth MJ
Immunol Rev; 2007 Dec; 220():82-101. PubMed ID: 17979841
[TBL] [Abstract][Full Text] [Related]
36. Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells.
Jänicke RU; Engels IH; Dunkern T; Kaina B; Schulze-Osthoff K; Porter AG
Oncogene; 2001 Aug; 20(36):5043-53. PubMed ID: 11526489
[TBL] [Abstract][Full Text] [Related]
37. Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner.
Werthmöller N; Frey B; Wunderlich R; Fietkau R; Gaipl US
Cell Death Dis; 2015 May; 6(5):e1761. PubMed ID: 25973681
[TBL] [Abstract][Full Text] [Related]
38. Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models.
Gravina GL; Marampon F; Sherris D; Vittorini F; Di Cesare E; Tombolini V; Lenzi A; Jannini EA; Festuccia C
Prostate; 2014 Jun; 74(8):852-68. PubMed ID: 24715588
[TBL] [Abstract][Full Text] [Related]
39. Radiotherapy and Immunotherapy: Improving Cancer Treatment through Synergy.
Reynders K; De Ruysscher D
Prog Tumor Res; 2015; 42():67-78. PubMed ID: 26383848
[TBL] [Abstract][Full Text] [Related]
40. Enhanced dendritic cell-based immunotherapy using low-dose cyclophosphamide and CD25-targeted antibody for transplanted Lewis lung carcinoma cells.
Son CH; Bae JH; Lee HR; Shin DY; Yang K; Park YS
J Immunother; 2015 Apr; 38(3):107-15. PubMed ID: 25751500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
